Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The AAPS journal 2021-11, Vol.23 (6), p.118-118, Article 118
Hauptverfasser:	McMahon, Megan E., Abbott, Alexander, Babayan, Yelizaveta, Carhart, Jenny, Chen, Chi-wan, Debie, Elke, Fu, Mingkun, Hoaglund-Hyzer, Cherokee, Lennard, Andrew, Li, Hanlin, Mazzeo, Tony, McCaig, Lori, Pischel, Sylvine, Qiu, Fenghe, Stephens, Dennis, Timpano, Robert, Webb, Debra, Wolfe, Chad, Woodlief, Kayla, Wu, Yan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Correction Pharmacology/Toxicology Pharmacy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	118
container_issue	6
container_start_page	118
container_title	The AAPS journal
container_volume	23
creator	McMahon, Megan E. Abbott, Alexander Babayan, Yelizaveta Carhart, Jenny Chen, Chi-wan Debie, Elke Fu, Mingkun Hoaglund-Hyzer, Cherokee Lennard, Andrew Li, Hanlin Mazzeo, Tony McCaig, Lori Pischel, Sylvine Qiu, Fenghe Stephens, Dennis Timpano, Robert Webb, Debra Wolfe, Chad Woodlief, Kayla Wu, Yan
description
doi_str_mv	10.1208/s12248-021-00646-1
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2598078683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2598078683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1641-7922d3e08e618e34a30114d92062cf0cc5e2db98d36112afc1d132f5c85e6d4d3</originalsourceid><addsrcrecordid>eNp9kMtOIzEQRVsjRhoe8wOz8pJNMy6723HYoRYEJCTEa205dnXG0LGDq3uRj-CfccgsWLGqUt17qlS3qv4APwPB9V8CIRpdcwE156pRNfyoDqFteT1rQB186X9VR0QvnEshAQ6r9y7ljG4MKbIxnbMuRQoes91NiPUps-eNtyNSkdlNd83ugdno2X3bscfRLsMQxi1bTAUaQkQ6Z5frZbYuxBXrprI7juwJ3b-YhrTafqIPgV7ZBRESrXfy41jO4SognVQ_ezsQ_v5fj6vnq8un7rq-vVvcdBe3tQPVQD2bC-Elco0KNMrGSg7Q-LngSrieO9ei8Mu59lIBCNs78CBF3zrdovKNl8fV6X7vJqe3CWk060AOh8FGTBMZ0c41n2mlZbGKvdXlRJSxN5sc1jZvDXCzy97sszcle_OZvYECyT1ExRxXmM1LmnIsL31HfQB6O4e5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2598078683</pqid></control><display><type>article</type><title>Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies</title><source>SpringerLink Journals - AutoHoldings</source><creator>McMahon, Megan E. ; Abbott, Alexander ; Babayan, Yelizaveta ; Carhart, Jenny ; Chen, Chi-wan ; Debie, Elke ; Fu, Mingkun ; Hoaglund-Hyzer, Cherokee ; Lennard, Andrew ; Li, Hanlin ; Mazzeo, Tony ; McCaig, Lori ; Pischel, Sylvine ; Qiu, Fenghe ; Stephens, Dennis ; Timpano, Robert ; Webb, Debra ; Wolfe, Chad ; Woodlief, Kayla ; Wu, Yan</creator><creatorcontrib>McMahon, Megan E. ; Abbott, Alexander ; Babayan, Yelizaveta ; Carhart, Jenny ; Chen, Chi-wan ; Debie, Elke ; Fu, Mingkun ; Hoaglund-Hyzer, Cherokee ; Lennard, Andrew ; Li, Hanlin ; Mazzeo, Tony ; McCaig, Lori ; Pischel, Sylvine ; Qiu, Fenghe ; Stephens, Dennis ; Timpano, Robert ; Webb, Debra ; Wolfe, Chad ; Woodlief, Kayla ; Wu, Yan</creatorcontrib><identifier>ISSN: 1550-7416</identifier><identifier>EISSN: 1550-7416</identifier><identifier>DOI: 10.1208/s12248-021-00646-1</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Biotechnology ; Correction ; Pharmacology/Toxicology ; Pharmacy</subject><ispartof>The AAPS journal, 2021-11, Vol.23 (6), p.118-118, Article 118</ispartof><rights>American Association of Pharmaceutical Scientists 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1208/s12248-021-00646-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1208/s12248-021-00646-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>McMahon, Megan E.</creatorcontrib><creatorcontrib>Abbott, Alexander</creatorcontrib><creatorcontrib>Babayan, Yelizaveta</creatorcontrib><creatorcontrib>Carhart, Jenny</creatorcontrib><creatorcontrib>Chen, Chi-wan</creatorcontrib><creatorcontrib>Debie, Elke</creatorcontrib><creatorcontrib>Fu, Mingkun</creatorcontrib><creatorcontrib>Hoaglund-Hyzer, Cherokee</creatorcontrib><creatorcontrib>Lennard, Andrew</creatorcontrib><creatorcontrib>Li, Hanlin</creatorcontrib><creatorcontrib>Mazzeo, Tony</creatorcontrib><creatorcontrib>McCaig, Lori</creatorcontrib><creatorcontrib>Pischel, Sylvine</creatorcontrib><creatorcontrib>Qiu, Fenghe</creatorcontrib><creatorcontrib>Stephens, Dennis</creatorcontrib><creatorcontrib>Timpano, Robert</creatorcontrib><creatorcontrib>Webb, Debra</creatorcontrib><creatorcontrib>Wolfe, Chad</creatorcontrib><creatorcontrib>Woodlief, Kayla</creatorcontrib><creatorcontrib>Wu, Yan</creatorcontrib><title>Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies</title><title>The AAPS journal</title><addtitle>AAPS J</addtitle><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Correction</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><issn>1550-7416</issn><issn>1550-7416</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOIzEQRVsjRhoe8wOz8pJNMy6723HYoRYEJCTEa205dnXG0LGDq3uRj-CfccgsWLGqUt17qlS3qv4APwPB9V8CIRpdcwE156pRNfyoDqFteT1rQB186X9VR0QvnEshAQ6r9y7ljG4MKbIxnbMuRQoes91NiPUps-eNtyNSkdlNd83ugdno2X3bscfRLsMQxi1bTAUaQkQ6Z5frZbYuxBXrprI7juwJ3b-YhrTafqIPgV7ZBRESrXfy41jO4SognVQ_ezsQ_v5fj6vnq8un7rq-vVvcdBe3tQPVQD2bC-Elco0KNMrGSg7Q-LngSrieO9ei8Mu59lIBCNs78CBF3zrdovKNl8fV6X7vJqe3CWk060AOh8FGTBMZ0c41n2mlZbGKvdXlRJSxN5sc1jZvDXCzy97sszcle_OZvYECyT1ExRxXmM1LmnIsL31HfQB6O4e5</recordid><startdate>20211115</startdate><enddate>20211115</enddate><creator>McMahon, Megan E.</creator><creator>Abbott, Alexander</creator><creator>Babayan, Yelizaveta</creator><creator>Carhart, Jenny</creator><creator>Chen, Chi-wan</creator><creator>Debie, Elke</creator><creator>Fu, Mingkun</creator><creator>Hoaglund-Hyzer, Cherokee</creator><creator>Lennard, Andrew</creator><creator>Li, Hanlin</creator><creator>Mazzeo, Tony</creator><creator>McCaig, Lori</creator><creator>Pischel, Sylvine</creator><creator>Qiu, Fenghe</creator><creator>Stephens, Dennis</creator><creator>Timpano, Robert</creator><creator>Webb, Debra</creator><creator>Wolfe, Chad</creator><creator>Woodlief, Kayla</creator><creator>Wu, Yan</creator><general>Springer International Publishing</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211115</creationdate><title>Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies</title><author>McMahon, Megan E. ; Abbott, Alexander ; Babayan, Yelizaveta ; Carhart, Jenny ; Chen, Chi-wan ; Debie, Elke ; Fu, Mingkun ; Hoaglund-Hyzer, Cherokee ; Lennard, Andrew ; Li, Hanlin ; Mazzeo, Tony ; McCaig, Lori ; Pischel, Sylvine ; Qiu, Fenghe ; Stephens, Dennis ; Timpano, Robert ; Webb, Debra ; Wolfe, Chad ; Woodlief, Kayla ; Wu, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1641-7922d3e08e618e34a30114d92062cf0cc5e2db98d36112afc1d132f5c85e6d4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Correction</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McMahon, Megan E.</creatorcontrib><creatorcontrib>Abbott, Alexander</creatorcontrib><creatorcontrib>Babayan, Yelizaveta</creatorcontrib><creatorcontrib>Carhart, Jenny</creatorcontrib><creatorcontrib>Chen, Chi-wan</creatorcontrib><creatorcontrib>Debie, Elke</creatorcontrib><creatorcontrib>Fu, Mingkun</creatorcontrib><creatorcontrib>Hoaglund-Hyzer, Cherokee</creatorcontrib><creatorcontrib>Lennard, Andrew</creatorcontrib><creatorcontrib>Li, Hanlin</creatorcontrib><creatorcontrib>Mazzeo, Tony</creatorcontrib><creatorcontrib>McCaig, Lori</creatorcontrib><creatorcontrib>Pischel, Sylvine</creatorcontrib><creatorcontrib>Qiu, Fenghe</creatorcontrib><creatorcontrib>Stephens, Dennis</creatorcontrib><creatorcontrib>Timpano, Robert</creatorcontrib><creatorcontrib>Webb, Debra</creatorcontrib><creatorcontrib>Wolfe, Chad</creatorcontrib><creatorcontrib>Woodlief, Kayla</creatorcontrib><creatorcontrib>Wu, Yan</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The AAPS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McMahon, Megan E.</au><au>Abbott, Alexander</au><au>Babayan, Yelizaveta</au><au>Carhart, Jenny</au><au>Chen, Chi-wan</au><au>Debie, Elke</au><au>Fu, Mingkun</au><au>Hoaglund-Hyzer, Cherokee</au><au>Lennard, Andrew</au><au>Li, Hanlin</au><au>Mazzeo, Tony</au><au>McCaig, Lori</au><au>Pischel, Sylvine</au><au>Qiu, Fenghe</au><au>Stephens, Dennis</au><au>Timpano, Robert</au><au>Webb, Debra</au><au>Wolfe, Chad</au><au>Woodlief, Kayla</au><au>Wu, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies</atitle><jtitle>The AAPS journal</jtitle><stitle>AAPS J</stitle><date>2021-11-15</date><risdate>2021</risdate><volume>23</volume><issue>6</issue><spage>118</spage><epage>118</epage><pages>118-118</pages><artnum>118</artnum><issn>1550-7416</issn><eissn>1550-7416</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><doi>10.1208/s12248-021-00646-1</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1550-7416
ispartof	The AAPS journal, 2021-11, Vol.23 (6), p.118-118, Article 118
issn	1550-7416 1550-7416
language	eng
recordid	cdi_proquest_miscellaneous_2598078683
source	SpringerLink Journals - AutoHoldings
subjects	Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Correction Pharmacology/Toxicology Pharmacy
title	Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T23%3A33%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20Considerations%20for%20Updates%20to%20ICH%20Q1%20and%20Q5C%20Stability%20Guidelines:%20Embracing%20Current%20Technology%20and%20Risk%20Assessment%20Strategies&rft.jtitle=The%20AAPS%20journal&rft.au=McMahon,%20Megan%20E.&rft.date=2021-11-15&rft.volume=23&rft.issue=6&rft.spage=118&rft.epage=118&rft.pages=118-118&rft.artnum=118&rft.issn=1550-7416&rft.eissn=1550-7416&rft_id=info:doi/10.1208/s12248-021-00646-1&rft_dat=%3Cproquest_cross%3E2598078683%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2598078683&rft_id=info:pmid/&rfr_iscdi=true